19.05.2015 • NewsDede WillamsSiltronicWacker

Siltronic Aims for Stock Listing Before Summer

Siltronic, electronics subsidiary of Munich-based Wacker Chemie and the world's third-largest maker of the silicon wafers used in semiconductor chips, aims to raise more than €150 million from an initial public offering planned to take place before the European summer holidays.

The German wafers producer said it will issue new shares as part of an equity increase, while parent Wacker will separately sell existing shares in the company to private and institutional investors on the German and Luxembourg stock market. Shares also will be offered for subscription in private placements outside the stock market.

Wacker intends to retain a majority stake in the electronics offshoot, at least for the short term.

Siltronic said it would use proceeds from the listing to reduce its debt. In a statement, CEO Christoph von Plotho said the company has "worked hard" to prepare for the ipo, implementing cost cuts totaling €135 million over the past two years.

Like its rivals in other countries, foremostly Japan, the Munich company has struggled with falling prices for silicon as personal computer markets have matured, limiting demand for microchips.

The worldwide silicon wafer market peaked at around $12.5 billion in 2007 but sales have plunged by more than a third since then, according to figures compiled by Gartner Inc. The market collapse has triggered a wave of consolidation in the global industry, necessitating plant closures at Siltronic.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.